Glenmark gets USFDA nod for alcohol abstinence drug

Glenmark Pharma said it has received US health regulator's approval to market generic version of Forest Laboratories' Campral Delayed Release Tablets.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news